Liver Cancer杂志（IF：13.8）主编、日本近畿大学医学院Masatoshi Kudo教授为此撰写了一篇社论，就不可切除和不适合经动脉化疗栓塞（TACE）治疗的中期肝 ...

《2024版共识》立足中国肝癌诊疗现状，进一步规范了肝癌新辅助及转化治疗的实施路径和方式，并于2024年9月3日正式发表于肝癌领域的权威期刊《Liver Cancer》（IF 11.6），这一学术里程碑标志着中国以外科为主导、多学科参与的肝癌新辅助及转化治疗理念已从实践探索走向共识，充分完善了目前肝癌肝癌诊疗的核心热点、难点。

SHANGHAI, Aug. 2 (Xinhua) -- A landmark report on the global prevention and control of liver cancer, led by Chinese experts and recently published in The Lancet, presents a new international roadmap ...

JERUSALEM, Aug. 7 (Xinhua) -- Israeli and U.S. researchers have discovered that disrupted brain-liver communication drives severe weight loss, or cachexia, in cancer patients, Israel's Weizmann ...